Back to search

Article

Fingolimod alters intrathecal B cell maturation in multiple sclerosis patients

2020-04-20

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: B cells are postulated to play multiple roles in the pathogenesis of multiple sclerosis (MS) including pathogenic antibody production, antigen-presentation and pro-inflammatory cytokine secretion. Natalizumab and fingolimod are effective MS therapies that disrupt lymphocyte migration but exert differential effects on B cell maturation and trafficking. Herein, we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f02bf5ca-edfb-54b5-97d6-e0f795c0351b
DOI
10.21203/rs.3.rs-23388/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fingolimod alters intrathecal B cell maturation in multiple sclerosis patientsDOI 10.21203/rs.3.rs-23388/v1
Select a neighboring publication to make it the new centre.